AM-Pharma Adds Regulatory, Business Development and Legal Expertise to Leadership Team

AM-Pharma B.V. today announced the appointment of Wolfgang Meder, Ph.D., as Vice President, Regulatory Affairs and Quality Management, and Laetitia Szaller as General Counsel & Vice President, Business Development.

SNF472 Mechanism of Action data published in British Journal of Pharmacology

Sanifit today announced that data examining the mechanism of action of SNF472, Sanifit’s lead compound in development, has been published in the British Journal of Pharmacology (BJP).

Ona Therapeutics raises €30M in Series A financing

Ysios Capital invests in Ona Therapeutics 30M€ round.

Aura Biosciences Presents Updated AU-011 Clinical Data at ARVO 2020

AU-011 Continues to Demonstrate a Favorable Safety Profile Along with Promising Tumor Control and Vision Preservation.

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

Ysios Capital presents its third fund of € 200M

The team has been strengthened with five Venture Partners to support the evaluation of potential investments.

Sanifit Enhances Leadership Team with New Executive Appointments

Vivet’s Second Gene Therapy Product, VTX-803 for PFIC3, Receives US and European Orphan Drug Designation

Galecto Appoints New Chair and Strengthens Board of Directors

Galecto Appoints Jonathan Freve as Chief Financial Officer